Navigation Links
Scientists can now differentiate between healthy cells and cancer cells
Date:1/5/2009

One of the current handicaps of cancer treatments is the difficulty of aiming these treatments at destroying malignant cells without killing healthy cells in the process. But a new study by McMaster University researchers has provided insight into how scientists might develop therapies and drugs that more carefully target cancer, while sparing normal healthy cells

Mick Bhatia, scientific director of the McMaster Stem Cell and Cancer Research Institute in the Michael G. DeGroote School of Medicine, and his team of investigators have demonstrated for the first time the difference between normal stem cells and cancer stem cells in humans.

The discovery, published in the prestigious journal Nature Biotechnology today, could eventually help with the further customization and targeting of cancer treatments for the individual patient. It will immediately provide a model to discover drugs using robotic screening for available molecules that may have untapped potential to eradicate cancer.

"Normal stem cells and cancer stem cells are hard to tell apart, and many have misconstrued really good stem cells for cancer stem cells that have gone bad - we now can tell the ones masquerading as normal stem cells from the bad, cancerous ones," said Bhatia.

"This also allows us to compare normal versus cancer stem cells from humans in the laboratory - define the differences in terms of genes they express and drugs they respond to. Essentially, we can now use this to find the "magic bullet", a drug or set of drugs that kill cancer stem cells first, and spare the normal healthy ones," he said.

"McMaster is uniquely positioned for this discovery platform, and this was the missing ingredient - we have one of the best screening/robotic platforms, chemical libraries and expertise in professors Eric Brown and Gerry Wright, who have discovered molecules to combat infectious disease. Now we can combine it all. This team now aims to k
'/>"/>

Contact: Veronica McGuire
vmcguir@mcmaster.ca
90-552-591-402-2169
McMaster University
Source:Eurekalert

Page: 1 2

Related biology news :

1. UK scientists working to help cut ID theft
2. Scientists show that mitochondrial DNA variants are linked to risk factors for type 2 diabetes
3. Comet probes reveal evidence of origin of life, scientists claim
4. Scientists link fragile X tremor/ataxia syndrome to binding protein in RNA
5. Male elephants get photo IDs from scientists
6. Scientists retrace evolution with first atomic structure of an ancient protein
7. Muscle mass: Scientists identify novel mode of transcriptional regulation during myogenesis
8. Carnegie Mellon scientists develop nanogels that enable controlled delivery of carbohydrate drugs
9. Clemson scientists shed light on molecules in living cells
10. Scientists tackle mystery mountain illness
11. T. rex quicker than Becks, say scientists

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/4/2009)...ass., Oct. 20 Aware, Inc...d technology and biometrics software, today report...September 30, 2009. ,, Michael Tzannes, Aware...rlier today, we announced an agreement to sell our...a new fabless semiconductor company being spun out...
(Date:11/4/2009)..., Oct. 26 BIO-key Intern... in finger-based biometric identification software...s at the AABB TXPO conference being held at the Ne...9. BIO-key will provide hands-on product demonstra...ology in booth #424. Also, at 5 PM on Monday, Octo...
(Date:11/4/2009)...Calif., Nov. 4 GenVault Corporatio...y, M.D., Ph.D., has joined its Board of Directors....f the Salk Institute, is an acclaimed physician-sc...he Salk Institute, Dr. Brody served as president o... the National Academy of Engineering and the Insti...
Breaking Biology News(10 mins):Aware, Inc. Reports Third Quarter 2009 Financial Results 2Aware, Inc. Reports Third Quarter 2009 Financial Results 3Aware, Inc. Reports Third Quarter 2009 Financial Results 4Aware, Inc. Reports Third Quarter 2009 Financial Results 5Aware, Inc. Reports Third Quarter 2009 Financial Results 6Aware, Inc. Reports Third Quarter 2009 Financial Results 7BIO-key(R) International Exhibiting at AABB TXPO 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 3Susies Big Adventure Explores Plastic Surgery In Saudi Arabia 53959 1Beetroot Juice May Boost Stamina 53957 1Beetroot Juice May Boost Stamina 53957 2School Closures May Not Be Necessary When Swine Flu Strikes 53955 1School Closures May Not Be Necessary When Swine Flu Strikes 53955 2School Closures May Not Be Necessary When Swine Flu Strikes 53955 3School Closures May Not Be Necessary When Swine Flu Strikes 53955 4
..., Mass. (Oct. 20, 2008) -- Two teams of scientists...echnology (HST) at Brigham and Women,s Hospital ha...elivery system that is biocompatible, efficient at...ese structures can deliver clinically approved dru...rs for the drug or generating toxic components, a ...
...chers are on the verge of unleashing the power of ... therapies, as decades of research begins to bear ... best kept secrets, but is now attracting fast gro...rmaceutical industry in the quest for novel drugs ...lly overcoming limitations and side effects of cur...
...thers purposely expose their offspring to their ow...use it is widely accepted that exposure to materna...ative impacts on offspring following birth. To exa...pen, evolutionary physiologists Oliver Love and To... maternally-derived stress hormone corticosterone ...
Other Biology News:European researchers harness unique properties of boron to develop new drugs and diagnostics 2European researchers harness unique properties of boron to develop new drugs and diagnostics 3Exposing chicks to maternal stress leads to long-term reproductive success 2
(Date:11/5/2009)...exas, Nov. 5 Wound Manag...that it has entered into a Letter of Intent to pur...lth Technologies, Inc. (OTC Bulletin Board: VHGI)....in cash and debt, 4,000,000 shares of WNDM and a r... the Veriscrip technology being acquired from VHGI...
(Date:11/5/2009)..., Nov. 5 SpineSmith Partners has s...co-develop a unique scaffold that mimics the struc...tion of several commercial products by SpineSmith,... believes the GenOsteo scaffold represents a signi...ique and ideal environment for the delivery of adu...
(Date:11/5/2009)... LASIK Surgery and vision correction experts...re actively involved at the recently concluded Ame...eeting in San Francisco, California. Dr. Stephen B...han Davidorf, MD, Dr. Peter Rapoza, MD, Dr. Michae...e Bowman, MD, Dr. Edward Manche, MD, and Dr. Parag...
(Date:11/4/2009)... The Human Anthrax Vaccine Program must be s...e feature film "A Call to Arms:2009 Edition&q...;Fatal Immunity: The Human Anthrax Vaccine Story&q...ent danger of top secret government science turned...countability to its victims. It is available for ...
Breaking Biology Technology:OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement 2Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 2Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 3Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 4Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 5Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 6Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 7Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 8Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 9Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 2Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 3Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 4Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 5Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 6Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 7
...iences Inc. today announced the development of a u...g from tissue hydration to the passivation of medi...is a series of patent-pending polymers that allow ... angle," says Andrew Loxley, PS, Director of New T...ed the system to develop an ocular formulation for...
...chnology today announced,that the company has obta...utilize Merck Eprova,s proprietary chiral lipid DO...ts in development based on the Versamune(TM),techn...oride shows enhanced,adjuvant activity compared to...enantiomerically pure DOTAP Chloride manufactured ...
...ork Sciences, Inc. (GNS) today announced that it h...Executive Officer of Stromedix, Inc. and former Ex... to its Board of Directors. , , Dr. Gilman has ...dix since June 2006. He was previously Executive ... Biogen in 1999 as Director of Molecular Biology a...
Other Biology Technology:Particle Sciences Completes Development of First Product Incorporating its Unique Surface Modification System 2PDS Biotechnology Corporation Finalizes Commercial Licensing Agreement with Merck Eprova AG to Utilize Merck Eprova's Enantiomers of DOTAP Chloride in Immunotherapies 2Gene Network Sciences Announces Michael Gilman as Board Member 2
Mouse Anti-Mouse Qa.m8 Monoclonal Antibody, Unconjugated, Clone 5035-24.1 from CEDARLANE Laboratories Limited
...s at the 9, 10, 12, and 13 positions. It is intend...ication of 13(S)-HODE by GC- or LC-mass spectromet...ic acid with plant and mammalian lipoxygenases. It...ells to the endothelium at concentrations around 1...
pcDNA4/His A B & C from Invitrogen
Adaptor Hind III - Sma I from Takara Mirus Bio
Biology Products: